Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended versus standard drospirenone/ethinyl estradiol regimen for premenstrual and menstrual symptoms
ISRCTN57661673Phase 3Completed
- Sponsor
- Libbs Farmacêutica
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of drospirenone and ethinyl estradiol in premenstrual syndrome (PMS) (2 arms), sponsored by Libbs Farmacêutica. Started Jan 2011; status: completed.
02
Drugs
drospirenoneethinyl estradiol
03
Conditions
premenstrual syndrome (PMS)
Beyond the preview
Go deeper on ISRCTN57661673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN57661673.